Winston A - Search Results

1

Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase.

Winston A, Pozniak A, Mandalia S, Gazzard B, Pillay D, Nelson M. Winston A, et al. AIDS. 2004 Apr 9;18(6):949-51. doi: 10.1097/00002030-200404090-00014. AIDS. 2004. PMID: 15060444 No abstract available.

2

The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients.

Winston A, Mandalia S, Pillay D, Gazzard B, Pozniak A. Winston A, et al. AIDS. 2002 Oct 18;16(15):2087-9. doi: 10.1097/00002030-200210180-00018. AIDS. 2002. PMID: 12370512

3

Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy.

Fox P, Stebbing J, Portsmouth S, Winston A, Frances N, Nelson M, Gazzard B, Bower M. Fox P, et al. Among authors: winston a. AIDS. 2003 Jan 24;17(2):279-80. doi: 10.1097/00002030-200301240-00028. AIDS. 2003. PMID: 12545098 No abstract available.

4

Dose escalation or immediate full dose when switching from efavirenz to nevirapine-based highly active antiretroviral therapy in HIV-1-infected individuals?

Winston A, Pozniak A, Smith N, Fletcher C, Mandalia S, Parmar D, Gibbons S, Back D, Gazzard B, Nelson M. Winston A, et al. AIDS. 2004 Feb 20;18(3):572-4. doi: 10.1097/00002030-200402200-00029. AIDS. 2004. PMID: 15090815 Clinical Trial.

5

The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individuals.

Winston A, Hales G, Amin J, van Schaick E, Cooper DA, Emery S; CREST investigators. Winston A, et al. AIDS. 2005 Sep 2;19(13):1393-9. doi: 10.1097/01.aids.0000181009.77632.36. AIDS. 2005. PMID: 16103770 Clinical Trial.

6

Different methods to calculate the inhibitory quotient of boosted single protease inhibitors and their association with virological response.

Winston A, Patel N, Back D, Khoo S, Bulbeck S, Mandalia S, Pozniak AL, Nelson M, Moyle G, Gazzard B, Boffito M. Winston A, et al. J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):675-6. doi: 10.1097/01.qui.0000209910.27997.d9. J Acquir Immune Defic Syndr. 2006. PMID: 16652044 No abstract available.

7

Effect of omeprazole on the pharmacokinetics of saquinavir-500 mg formulation with ritonavir in healthy male and female volunteers.

Winston A, Back D, Fletcher C, Robinson L, Unsworth J, Tolowinska I, Schutz M, Pozniak AL, Gazzard B, Boffito M. Winston A, et al. AIDS. 2006 Jun 26;20(10):1401-6. doi: 10.1097/01.aids.0000233573.41597.8a. AIDS. 2006. PMID: 16791014

8

Pharmacokinetics and antiretroviral response to darunavir/ritonavir and etravirine combination in patients with high-level viral resistance.

Boffito M, Winston A, Jackson A, Fletcher C, Pozniak A, Nelson M, Moyle G, Tolowinska I, Hoetelmans R, Miralles D, Gazzard B. Boffito M, et al. Among authors: winston a. AIDS. 2007 Jul 11;21(11):1449-55. doi: 10.1097/QAD.0b013e3282170ab1. AIDS. 2007. PMID: 17589191

9

Are disulfiram-like reactions associated with abacavir-containing antiretroviral regimens in clinical practice?

Barber TJ, Marett B, Waldron S, Portsmouth S, Mackie NE, Weston R, Winston A. Barber TJ, et al. Among authors: winston a. AIDS. 2007 Aug 20;21(13):1823-4. doi: 10.1097/QAD.0b013e328270b88d. AIDS. 2007. PMID: 17690585

10

Polymorphisms at position 245 of HIV reverse transcriptase do not accurately predict the presence of human leukocyte antigen B*5701.

Waters LJ, Mackie NE, Pozniak A, Winston A. Waters LJ, et al. Among authors: winston a. Clin Infect Dis. 2007 Nov 1;45(9):1243-4; author reply 1244-5. doi: 10.1086/521940. Clin Infect Dis. 2007. PMID: 17918094 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

497 results

Search Page

Filters